Allogene
Allogene Overview
Allogene is focusing on creating and leading the next revolution in cell therapy by delivering allogeneic CAR T cell products for blood cancers, solid tumors, and autoimmune diseases.
GOOD · 50–74What a 52 means
Good at proving value
Allogene quantifies outcomes in many case studies, but coverage is uneven across products, industries, or regions.
Poor0–24
Average25–49
Good50–74
Excellent75–100
NO VALUE MODEL YET
Want to bring your ROI sheet to life?
With ValueCore, you can turn your ROI sheet into a live business case your sellers can use. If you don’t have one, ValueCore and our AI can help you build one.
Categories
Explore where this organization appears across the ValueHub taxonomy
Key Findings
Industries
- •cell therapy
- •biotechnology
Featured Products
- •Cemacabtagene ansegedleucel (cema-cel)
- •ALLO-316
- •ALLO-329